Rank | Gene Set | Z-score |
---|---|---|
1 | central nervous system myelination (GO:0022010) | 8.24647504 |
2 | axon ensheathment in central nervous system (GO:0032291) | 8.24647504 |
3 | desmosome organization (GO:0002934) | 6.77158043 |
4 | fatty acid elongation (GO:0030497) | 6.17946500 |
5 | keratinocyte proliferation (GO:0043616) | 5.44793762 |
6 | membrane raft organization (GO:0031579) | 4.91263080 |
7 | ensheathment of neurons (GO:0007272) | 4.74668475 |
8 | axon ensheathment (GO:0008366) | 4.74668475 |
9 | myelination (GO:0042552) | 4.73965899 |
10 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.72555644 |
11 | cell-substrate junction assembly (GO:0007044) | 4.67648667 |
12 | regulation of water loss via skin (GO:0033561) | 4.65595786 |
13 | establishment of skin barrier (GO:0061436) | 4.61358471 |
14 | cell adhesion mediated by integrin (GO:0033627) | 4.57283818 |
15 | surfactant homeostasis (GO:0043129) | 4.52118841 |
16 | hypotonic response (GO:0006971) | 4.46518389 |
17 | response to methylmercury (GO:0051597) | 4.26911674 |
18 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.09242121 |
19 | diterpenoid biosynthetic process (GO:0016102) | 3.94910996 |
20 | myelin maintenance (GO:0043217) | 3.92294599 |
21 | negative regulation of neurotransmitter transport (GO:0051589) | 3.89025715 |
22 | COPI coating of Golgi vesicle (GO:0048205) | 3.88731117 |
23 | Golgi transport vesicle coating (GO:0048200) | 3.88731117 |
24 | skin morphogenesis (GO:0043589) | 3.87690114 |
25 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.87136113 |
26 | L-amino acid import (GO:0043092) | 3.86055891 |
27 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.74554874 |
28 | chemical homeostasis within a tissue (GO:0048875) | 3.70064001 |
29 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.67908473 |
30 | peptidyl-proline hydroxylation (GO:0019511) | 3.64939775 |
31 | cholesterol biosynthetic process (GO:0006695) | 3.64208705 |
32 | pyrimidine-containing compound salvage (GO:0008655) | 3.63247447 |
33 | pyrimidine nucleoside salvage (GO:0043097) | 3.63247447 |
34 | mesodermal cell differentiation (GO:0048333) | 3.59951985 |
35 | protein hydroxylation (GO:0018126) | 3.53004988 |
36 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.52164077 |
37 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.51903040 |
38 | negative regulation of protein localization to cell surface (GO:2000009) | 3.50606948 |
39 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.48190157 |
40 | activation of Rac GTPase activity (GO:0032863) | 3.33739193 |
41 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.26587994 |
42 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.23455672 |
43 | mammary gland epithelial cell proliferation (GO:0033598) | 3.21168355 |
44 | sterol biosynthetic process (GO:0016126) | 3.19692397 |
45 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.16108958 |
46 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.15822425 |
47 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.14973325 |
48 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.13044771 |
49 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.13044771 |
50 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.11571348 |
51 | presynaptic membrane organization (GO:0097090) | 3.10910410 |
52 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.10869277 |
53 | regulation of lipoprotein metabolic process (GO:0050746) | 3.10728937 |
54 | glycerophospholipid catabolic process (GO:0046475) | 3.10277744 |
55 | regulation of metalloenzyme activity (GO:0048552) | 3.10174335 |
56 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.09674894 |
57 | synaptic vesicle maturation (GO:0016188) | 3.08524017 |
58 | protein retention in ER lumen (GO:0006621) | 3.07449216 |
59 | keratinocyte differentiation (GO:0030216) | 3.06651956 |
60 | establishment of mitochondrion localization (GO:0051654) | 3.05742949 |
61 | amino acid import (GO:0043090) | 3.05412422 |
62 | very long-chain fatty acid metabolic process (GO:0000038) | 3.05379506 |
63 | eye photoreceptor cell differentiation (GO:0001754) | 3.04753415 |
64 | photoreceptor cell differentiation (GO:0046530) | 3.04753415 |
65 | multicellular organismal water homeostasis (GO:0050891) | 3.04423939 |
66 | import into cell (GO:0098657) | 3.02442765 |
67 | apical protein localization (GO:0045176) | 3.02406229 |
68 | positive regulation of epidermis development (GO:0045684) | 3.01867535 |
69 | oligodendrocyte differentiation (GO:0048709) | 3.01340412 |
70 | decidualization (GO:0046697) | 3.00978453 |
71 | response to peptidoglycan (GO:0032494) | 2.99668965 |
72 | keratinization (GO:0031424) | 2.98042210 |
73 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.94535518 |
74 | locomotory exploration behavior (GO:0035641) | 2.92824205 |
75 | dendritic spine morphogenesis (GO:0060997) | 2.92157659 |
76 | regulation of collateral sprouting (GO:0048670) | 2.90811556 |
77 | asymmetric protein localization (GO:0008105) | 2.88740570 |
78 | neuron cell-cell adhesion (GO:0007158) | 2.87324016 |
79 | gap junction assembly (GO:0016264) | 2.86166902 |
80 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.84705854 |
81 | L-phenylalanine catabolic process (GO:0006559) | 2.84705854 |
82 | adult walking behavior (GO:0007628) | 2.84648334 |
83 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.83080828 |
84 | * regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.82798859 |
85 | amyloid precursor protein metabolic process (GO:0042982) | 2.82504952 |
86 | sphingosine metabolic process (GO:0006670) | 2.81905727 |
87 | adenosine receptor signaling pathway (GO:0001973) | 2.81587105 |
88 | auditory behavior (GO:0031223) | 2.81081629 |
89 | response to vitamin D (GO:0033280) | 2.80294824 |
90 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.80119604 |
91 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.79692186 |
92 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.79134493 |
93 | neuronal action potential propagation (GO:0019227) | 2.78964565 |
94 | substrate-dependent cell migration (GO:0006929) | 2.73305559 |
95 | iron coordination entity transport (GO:1901678) | 2.73043813 |
96 | presynaptic membrane assembly (GO:0097105) | 2.72944596 |
97 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.70541525 |
98 | creatine metabolic process (GO:0006600) | 2.69665123 |
99 | membrane tubulation (GO:0097320) | 2.69022870 |
100 | membrane budding (GO:0006900) | 2.67152492 |
101 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.67024034 |
102 | transmission of nerve impulse (GO:0019226) | 2.66759823 |
103 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.66440909 |
104 | mating behavior (GO:0007617) | 2.65859297 |
105 | hair cycle (GO:0042633) | 2.65793934 |
106 | molting cycle (GO:0042303) | 2.65793934 |
107 | positive regulation of tissue remodeling (GO:0034105) | 2.64807741 |
108 | isoprenoid biosynthetic process (GO:0008299) | 2.63509138 |
109 | prepulse inhibition (GO:0060134) | 2.62292165 |
110 | water homeostasis (GO:0030104) | 2.61541613 |
111 | myelination in peripheral nervous system (GO:0022011) | 2.61304372 |
112 | peripheral nervous system axon ensheathment (GO:0032292) | 2.61304372 |
113 | 4-hydroxyproline metabolic process (GO:0019471) | 2.61012483 |
114 | nerve growth factor signaling pathway (GO:0038180) | 2.59892302 |
115 | glycine transport (GO:0015816) | 2.59571822 |
116 | neuronal ion channel clustering (GO:0045161) | 2.58730193 |
117 | signal complex assembly (GO:0007172) | 2.58684082 |
118 | astrocyte development (GO:0014002) | 2.58309232 |
119 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.58076290 |
120 | regulation of synapse structural plasticity (GO:0051823) | 2.57661870 |
121 | synaptic transmission, dopaminergic (GO:0001963) | 2.57475462 |
122 | iron ion import (GO:0097286) | 2.56696393 |
123 | regulation of keratinocyte proliferation (GO:0010837) | 2.56067295 |
124 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.54942928 |
125 | cellular copper ion homeostasis (GO:0006878) | 2.54379807 |
126 | regulation of hair follicle development (GO:0051797) | 2.54247826 |
127 | neuron remodeling (GO:0016322) | 2.53789490 |
128 | terpenoid biosynthetic process (GO:0016114) | 2.53325032 |
129 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.52782754 |
130 | acyl-CoA biosynthetic process (GO:0071616) | 2.52343573 |
131 | thioester biosynthetic process (GO:0035384) | 2.52343573 |
132 | negative regulation of anoikis (GO:2000811) | 2.50844458 |
133 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.50021922 |
134 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.49844055 |
135 | epithelial cell-cell adhesion (GO:0090136) | 2.49283181 |
136 | epidermis development (GO:0008544) | 2.48443002 |
137 | regulation of keratinocyte differentiation (GO:0045616) | 2.48226830 |
138 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.47996597 |
139 | positive regulation of adherens junction organization (GO:1903393) | 2.47878574 |
140 | mechanosensory behavior (GO:0007638) | 2.47829201 |
141 | ER overload response (GO:0006983) | 2.47769602 |
142 | hepatocyte differentiation (GO:0070365) | 2.47380391 |
143 | glucose 6-phosphate metabolic process (GO:0051156) | 2.47337058 |
144 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.46463721 |
145 | response to lipoprotein particle (GO:0055094) | 2.46394588 |
146 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.45783200 |
147 | dendrite morphogenesis (GO:0048813) | 2.45644333 |
148 | positive regulation of focal adhesion assembly (GO:0051894) | 2.45390762 |
149 | positive regulation of cell junction assembly (GO:1901890) | 2.45390762 |
150 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.45040308 |
151 | regulation of podosome assembly (GO:0071801) | 2.44908514 |
152 | positive regulation of hair follicle development (GO:0051798) | 2.44793058 |
153 | positive regulation of hair cycle (GO:0042635) | 2.44793058 |
154 | neuromuscular process controlling balance (GO:0050885) | 2.43955061 |
155 | diol metabolic process (GO:0034311) | 2.43696239 |
156 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.43251691 |
157 | neuron recognition (GO:0008038) | 2.43007753 |
158 | axon development (GO:0061564) | 2.42239298 |
159 | protein localization to endosome (GO:0036010) | 2.42211461 |
160 | intermediate filament organization (GO:0045109) | 2.41764746 |
161 | negative regulation of necroptotic process (GO:0060546) | 2.41540323 |
162 | sphingoid metabolic process (GO:0046519) | 2.40985718 |
163 | regulation of dopamine metabolic process (GO:0042053) | 2.40464122 |
164 | regulation of catecholamine metabolic process (GO:0042069) | 2.40464122 |
165 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.40393907 |
166 | heme transport (GO:0015886) | 2.40205796 |
167 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.39540538 |
168 | substantia nigra development (GO:0021762) | 2.38905456 |
169 | magnesium ion transport (GO:0015693) | 2.38448668 |
170 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.38292352 |
171 | L-phenylalanine metabolic process (GO:0006558) | 2.38292352 |
172 | regulation of neurotransmitter uptake (GO:0051580) | 2.38158382 |
173 | behavioral response to cocaine (GO:0048148) | 2.37791140 |
174 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.37456292 |
175 | negative regulation of axonogenesis (GO:0050771) | 2.37228200 |
176 | regulation of early endosome to late endosome transport (GO:2000641) | 2.36779814 |
177 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.36692465 |
178 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.36666361 |
179 | response to auditory stimulus (GO:0010996) | 2.36483657 |
180 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.36316215 |
181 | gamma-aminobutyric acid transport (GO:0015812) | 2.33811353 |
182 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.33007494 |
183 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.32786701 |
184 | regulation of necroptotic process (GO:0060544) | 2.32556387 |
185 | regulation of transforming growth factor beta production (GO:0071634) | 2.32453223 |
186 | nucleoside salvage (GO:0043174) | 2.31933783 |
187 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.31882267 |
188 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.31882267 |
189 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.31632763 |
190 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.31275615 |
191 | membrane protein ectodomain proteolysis (GO:0006509) | 2.30351346 |
192 | epidermal cell differentiation (GO:0009913) | 2.30350057 |
193 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.29596050 |
194 | response to muramyl dipeptide (GO:0032495) | 2.28955071 |
195 | neutrophil activation involved in immune response (GO:0002283) | 2.28917880 |
196 | endocytic recycling (GO:0032456) | 2.28719099 |
197 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.27985217 |
198 | detection of other organism (GO:0098543) | 2.27247176 |
199 | hemidesmosome assembly (GO:0031581) | 10.6623352 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.98161557 |
2 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 4.53698604 |
3 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 3.07095277 |
4 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 3.07095277 |
5 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.94882790 |
6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.65373628 |
7 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.62765349 |
8 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.59003743 |
9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.53197047 |
10 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.45454864 |
11 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.45268356 |
12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42556462 |
13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.28813903 |
14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.27433522 |
15 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.24712314 |
16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.18405135 |
17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.18405135 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18023575 |
19 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.16991976 |
20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.13062188 |
21 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.08938935 |
22 | ATF3_27146783_Chip-Seq_COLON_Human | 2.07669817 |
23 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07133247 |
24 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.07011101 |
25 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.06656592 |
26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.05084382 |
27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.04430135 |
28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.03553161 |
29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03175158 |
30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.01601186 |
31 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.01572914 |
32 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.01094129 |
33 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.00005134 |
34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.5319027 |
35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94438814 |
36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.92374028 |
37 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.91996469 |
38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91710467 |
39 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.91263248 |
40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.87385855 |
41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86401423 |
42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.86044371 |
43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84054411 |
44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.81295998 |
45 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80989406 |
46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.79403203 |
47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75526681 |
48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73418052 |
49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72204387 |
50 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.66866439 |
51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65392080 |
52 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.64417001 |
53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62684813 |
54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.61152003 |
55 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.60859918 |
56 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.60614912 |
57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.59560697 |
58 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.58346034 |
59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58268803 |
60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55432115 |
61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54758087 |
62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54632019 |
63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.54256282 |
64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53858349 |
65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53384598 |
66 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52473766 |
67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.51004465 |
68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45047936 |
69 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44795749 |
70 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.43235098 |
71 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.41672876 |
72 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.41609580 |
73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40880732 |
74 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.38987274 |
75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36172613 |
76 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34796085 |
77 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33505875 |
78 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33389838 |
79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32966873 |
80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.32380037 |
81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.31836081 |
82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30332012 |
83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28397832 |
84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27619886 |
85 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26040509 |
86 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25350562 |
87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25300505 |
88 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24441621 |
89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22711347 |
90 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22678848 |
91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22653284 |
92 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21706091 |
93 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20773812 |
94 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20228139 |
95 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.19574792 |
96 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19479007 |
97 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.19198142 |
98 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18620757 |
99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17587496 |
100 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.16714903 |
101 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16630203 |
102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16514044 |
103 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.16105116 |
104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15869456 |
105 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.14806252 |
106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14129241 |
107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13061574 |
108 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.12877746 |
109 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12773990 |
110 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12564954 |
111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12457392 |
112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12457392 |
113 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10556718 |
114 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10255253 |
115 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10169292 |
116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10048023 |
117 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09778442 |
118 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09730540 |
119 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08778858 |
120 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08569849 |
121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08228516 |
122 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08158087 |
123 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07799402 |
124 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07430487 |
125 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06072749 |
126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05564715 |
127 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05258466 |
128 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02362680 |
129 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02051138 |
130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01463436 |
131 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00991558 |
132 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00811377 |
133 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00563502 |
134 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00250497 |
135 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99640666 |
136 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99225074 |
137 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98976177 |
138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98917883 |
139 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98308041 |
140 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97920593 |
141 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.96407217 |
142 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95396182 |
143 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94654788 |
144 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94446464 |
145 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94014158 |
146 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.93130180 |
147 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.93033159 |
148 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.92708215 |
149 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.92440249 |
150 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91386507 |
151 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91262820 |
152 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91102519 |
153 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91047976 |
154 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90914062 |
155 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90613020 |
156 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90005904 |
157 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.89787440 |
158 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88949193 |
159 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88826150 |
160 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88045757 |
161 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87850601 |
162 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87232695 |
163 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87015694 |
164 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.86688199 |
165 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.86652344 |
166 | AR_25329375_ChIP-Seq_VCAP_Human | 0.86463273 |
167 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86247542 |
168 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86247542 |
169 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85837939 |
170 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85136302 |
171 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.84953890 |
172 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84861833 |
173 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.84820252 |
174 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84582985 |
175 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.84427406 |
176 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84290819 |
177 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.84077206 |
178 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83933016 |
179 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83620651 |
180 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.81377735 |
181 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.81352063 |
182 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.80983340 |
183 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79351790 |
184 | KDM2B_26808549_Chip-Seq_K562_Human | 0.78295767 |
185 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75990542 |
186 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.75927980 |
187 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.75456977 |
188 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.74944713 |
189 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74224092 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002822_catalepsy | 4.35672726 |
2 | MP0000920_abnormal_myelination | 3.99952122 |
3 | MP0003880_abnormal_central_pattern | 3.68994423 |
4 | MP0004859_abnormal_synaptic_plasticity | 3.57348439 |
5 | MP0003453_abnormal_keratinocyte_physiol | 3.22387938 |
6 | MP0003566_abnormal_cell_adhesion | 3.09179125 |
7 | MP0004270_analgesia | 3.02791537 |
8 | MP0003690_abnormal_glial_cell | 2.88263616 |
9 | MP0003941_abnormal_skin_development | 2.81924936 |
10 | MP0005023_abnormal_wound_healing | 2.70242178 |
11 | MP0004272_abnormal_basement_membrane | 2.69617084 |
12 | MP0003329_amyloid_beta_deposits | 2.67324500 |
13 | MP0001216_abnormal_epidermal_layer | 2.58751334 |
14 | MP0001486_abnormal_startle_reflex | 2.56472913 |
15 | MP0003635_abnormal_synaptic_transmissio | 2.52950784 |
16 | MP0002060_abnormal_skin_morphology | 2.45265512 |
17 | MP0002064_seizures | 2.41946213 |
18 | MP0004885_abnormal_endolymph | 2.38733351 |
19 | MP0003705_abnormal_hypodermis_morpholog | 2.36861676 |
20 | MP0009745_abnormal_behavioral_response | 2.33872934 |
21 | MP0002272_abnormal_nervous_system | 2.31949749 |
22 | MP0001529_abnormal_vocalization | 2.30209474 |
23 | MP0008260_abnormal_autophagy | 2.29707455 |
24 | MP0005423_abnormal_somatic_nervous | 2.28853604 |
25 | MP0004264_abnormal_extraembryonic_tissu | 2.16717883 |
26 | MP0005501_abnormal_skin_physiology | 2.15588370 |
27 | MP0002063_abnormal_learning/memory/cond | 2.10332180 |
28 | MP0002877_abnormal_melanocyte_morpholog | 2.06539867 |
29 | MP0010352_gastrointestinal_tract_polyps | 2.03668199 |
30 | MP0003950_abnormal_plasma_membrane | 2.03396589 |
31 | MP0005409_darkened_coat_color | 2.00343705 |
32 | MP0004947_skin_inflammation | 1.99898683 |
33 | MP0005164_abnormal_response_to | 1.90441023 |
34 | MP0004742_abnormal_vestibular_system | 1.87219516 |
35 | MP0001849_ear_inflammation | 1.86017038 |
36 | MP0000858_altered_metastatic_potential | 1.84620442 |
37 | MP0002572_abnormal_emotion/affect_behav | 1.82174590 |
38 | MP0003091_abnormal_cell_migration | 1.81828610 |
39 | MP0003634_abnormal_glial_cell | 1.80299062 |
40 | MP0009046_muscle_twitch | 1.79209717 |
41 | MP0000778_abnormal_nervous_system | 1.74689544 |
42 | MP0001905_abnormal_dopamine_level | 1.72488734 |
43 | MP0004142_abnormal_muscle_tone | 1.72273294 |
44 | MP0000678_abnormal_parathyroid_gland | 1.71131774 |
45 | MP0002098_abnormal_vibrissa_morphology | 1.68864347 |
46 | MP0003300_gastrointestinal_ulcer | 1.68843041 |
47 | MP0003633_abnormal_nervous_system | 1.57481327 |
48 | MP0003632_abnormal_nervous_system | 1.57368048 |
49 | MP0002734_abnormal_mechanical_nocicepti | 1.55602721 |
50 | MP0005085_abnormal_gallbladder_physiolo | 1.54039897 |
51 | MP0000604_amyloidosis | 1.52572392 |
52 | MP0003631_nervous_system_phenotype | 1.51721603 |
53 | * MP0010771_integument_phenotype | 1.49717387 |
54 | MP0006082_CNS_inflammation | 1.48091975 |
55 | MP0001485_abnormal_pinna_reflex | 1.43955971 |
56 | MP0002229_neurodegeneration | 1.43812863 |
57 | MP0009785_altered_susceptibility_to | 1.43330174 |
58 | MP0001968_abnormal_touch/_nociception | 1.38788208 |
59 | MP0001440_abnormal_grooming_behavior | 1.38489486 |
60 | MP0001177_atelectasis | 1.38428949 |
61 | MP0000579_abnormal_nail_morphology | 1.38129271 |
62 | MP0003303_peritoneal_inflammation | 1.37451079 |
63 | MP0003195_calcinosis | 1.37326049 |
64 | MP0003436_decreased_susceptibility_to | 1.35339403 |
65 | MP0000955_abnormal_spinal_cord | 1.35169273 |
66 | MP0000383_abnormal_hair_follicle | 1.34577764 |
67 | MP0001970_abnormal_pain_threshold | 1.33591520 |
68 | MP0002139_abnormal_hepatobiliary_system | 1.33234900 |
69 | MP0003828_pulmonary_edema | 1.31903637 |
70 | MP0000377_abnormal_hair_follicle | 1.31423298 |
71 | MP0008569_lethality_at_weaning | 1.31342053 |
72 | MP0005451_abnormal_body_composition | 1.29878824 |
73 | MP0005646_abnormal_pituitary_gland | 1.29796596 |
74 | MP0004883_abnormal_blood_vessel | 1.28318407 |
75 | * MP0010678_abnormal_skin_adnexa | 1.28147198 |
76 | MP0009053_abnormal_anal_canal | 1.28077616 |
77 | MP0005360_urolithiasis | 1.27771520 |
78 | MP0002733_abnormal_thermal_nociception | 1.27156934 |
79 | MP0004043_abnormal_pH_regulation | 1.25989315 |
80 | MP0002796_impaired_skin_barrier | 1.25003856 |
81 | MP0008875_abnormal_xenobiotic_pharmacok | 1.23321311 |
82 | MP0004782_abnormal_surfactant_physiolog | 1.22301079 |
83 | MP0005171_absent_coat_pigmentation | 1.20799544 |
84 | MP0000462_abnormal_digestive_system | 1.20681659 |
85 | MP0002067_abnormal_sensory_capabilities | 1.20217153 |
86 | MP0005386_behavior/neurological_phenoty | 1.19964289 |
87 | MP0004924_abnormal_behavior | 1.19964289 |
88 | MP0003075_altered_response_to | 1.19946366 |
89 | MP0002882_abnormal_neuron_morphology | 1.19351267 |
90 | MP0002066_abnormal_motor_capabilities/c | 1.18958024 |
91 | MP0009780_abnormal_chondrocyte_physiolo | 1.18558448 |
92 | MP0005076_abnormal_cell_differentiation | 1.17396334 |
93 | MP0005257_abnormal_intraocular_pressure | 1.14959873 |
94 | MP0002090_abnormal_vision | 1.14919507 |
95 | MP0002148_abnormal_hypersensitivity_rea | 1.14558122 |
96 | MP0004381_abnormal_hair_follicle | 1.11872401 |
97 | MP0000627_abnormal_mammary_gland | 1.10891625 |
98 | MP0005551_abnormal_eye_electrophysiolog | 1.10264401 |
99 | MP0009931_abnormal_skin_appearance | 1.08018966 |
100 | MP0000537_abnormal_urethra_morphology | 1.07623057 |
101 | MP0005275_abnormal_skin_tensile | 1.06906344 |
102 | MP0005410_abnormal_fertilization | 1.06471704 |
103 | MP0003724_increased_susceptibility_to | 1.05017377 |
104 | MP0002557_abnormal_social/conspecific_i | 1.04609026 |
105 | MP0002332_abnormal_exercise_endurance | 1.04604709 |
106 | MP0005165_increased_susceptibility_to | 1.04458526 |
107 | MP0001501_abnormal_sleep_pattern | 1.04331860 |
108 | MP0005058_abnormal_lysosome_morphology | 1.03203022 |
109 | MP0003183_abnormal_peptide_metabolism | 1.03103149 |
110 | MP0003136_yellow_coat_color | 1.02210481 |
111 | MP0005166_decreased_susceptibility_to | 1.01794488 |
112 | MP0009840_abnormal_foam_cell | 0.99876437 |
113 | MP0003806_abnormal_nucleotide_metabolis | 0.98596052 |
114 | MP0002736_abnormal_nociception_after | 0.98585597 |
115 | MP0001963_abnormal_hearing_physiology | 0.96626436 |
116 | MP0002419_abnormal_innate_immunity | 0.95831772 |
117 | MP0001299_abnormal_eye_distance/ | 0.92888779 |
118 | MP0002118_abnormal_lipid_homeostasis | 0.92289193 |
119 | MP0005248_abnormal_Harderian_gland | 0.91295026 |
120 | MP0010155_abnormal_intestine_physiology | 0.91233040 |
121 | MP0001346_abnormal_lacrimal_gland | 0.90358558 |
122 | MP0002896_abnormal_bone_mineralization | 0.89962812 |
123 | MP0005167_abnormal_blood-brain_barrier | 0.89895771 |
124 | MP0010234_abnormal_vibrissa_follicle | 0.89367333 |
125 | MP0001191_abnormal_skin_condition | 0.85056864 |
126 | MP0001915_intracranial_hemorrhage | 0.84259336 |
127 | MP0004811_abnormal_neuron_physiology | 0.83948299 |
128 | MP0002735_abnormal_chemical_nociception | 0.83890509 |
129 | MP0008874_decreased_physiological_sensi | 0.83874514 |
130 | MP0001502_abnormal_circadian_rhythm | 0.83756514 |
131 | MP0003448_altered_tumor_morphology | 0.83619133 |
132 | MP0001666_abnormal_nutrient_absorption | 0.83228173 |
133 | MP0005621_abnormal_cell_physiology | 0.82424465 |
134 | MP0001533_abnormal_skeleton_physiology | 0.81090462 |
135 | MP0003191_abnormal_cellular_cholesterol | 0.80046362 |
136 | MP0004134_abnormal_chest_morphology | 0.79448285 |
137 | MP0002152_abnormal_brain_morphology | 0.78858414 |
138 | MP0003656_abnormal_erythrocyte_physiolo | 0.78790956 |
139 | MP0005365_abnormal_bile_salt | 0.77833955 |
140 | MP0002184_abnormal_innervation | 0.77805626 |
141 | MP0000467_abnormal_esophagus_morphology | 0.77690318 |
142 | MP0001348_abnormal_lacrimal_gland | 0.77248767 |
143 | * MP0000647_abnormal_sebaceous_gland | 0.77228425 |
144 | MP0003252_abnormal_bile_duct | 0.76821770 |
145 | MP0004510_myositis | 0.76093440 |
146 | MP0005623_abnormal_meninges_morphology | 0.75985129 |
147 | MP0004858_abnormal_nervous_system | 0.75536621 |
148 | MP0002752_abnormal_somatic_nervous | 0.75261542 |
149 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74604227 |
150 | MP0005645_abnormal_hypothalamus_physiol | 0.74311159 |
151 | MP0002998_abnormal_bone_remodeling | 0.73351719 |
152 | MP0004233_abnormal_muscle_weight | 0.73199634 |
153 | MP0002138_abnormal_hepatobiliary_system | 0.72813920 |
154 | MP0004185_abnormal_adipocyte_glucose | 0.72216416 |
155 | MP0005025_abnormal_response_to | 0.70930877 |
156 | MP0000343_altered_response_to | 0.70629710 |
157 | MP0000747_muscle_weakness | 0.70342608 |
158 | MP0002295_abnormal_pulmonary_circulatio | 0.69668802 |
159 | MP0002909_abnormal_adrenal_gland | 0.69640768 |
160 | MP0001881_abnormal_mammary_gland | 0.69224560 |
161 | MP0000762_abnormal_tongue_morphology | 0.68776024 |
162 | * MP0000367_abnormal_coat/_hair | 0.68770255 |
163 | MP0005464_abnormal_platelet_physiology | 0.68587779 |
164 | MP0001853_heart_inflammation | 0.67237638 |
165 | MP0002234_abnormal_pharynx_morphology | 0.66043834 |
166 | MP0001790_abnormal_immune_system | 0.65997926 |
167 | MP0005387_immune_system_phenotype | 0.65997926 |
168 | MP0001845_abnormal_inflammatory_respons | 0.64896858 |
169 | MP0002069_abnormal_eating/drinking_beha | 0.64835886 |
170 | MP0002089_abnormal_postnatal_growth/wei | 0.64363050 |
171 | MP0008872_abnormal_physiological_respon | 0.63533452 |
172 | MP0000566_synostosis | 0.63151615 |
173 | MP0000685_abnormal_immune_system | 0.62684316 |
174 | MP0008469_abnormal_protein_level | 0.61188772 |
175 | MP0004019_abnormal_vitamin_homeostasis | 0.60276068 |
176 | MP0002452_abnormal_antigen_presenting | 0.59510210 |
177 | MP0000427_abnormal_hair_cycle | 0.59255606 |
178 | * MP0005193_abnormal_anterior_eye | 0.59175262 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Onycholysis (HP:0001806) | 6.78102626 |
2 | Milia (HP:0001056) | 6.64616027 |
3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.95020723 |
4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.95020723 |
5 | Neurofibrillary tangles (HP:0002185) | 5.92227106 |
6 | Plantar hyperkeratosis (HP:0007556) | 5.85490660 |
7 | Fragile nails (HP:0001808) | 5.37782662 |
8 | Thick nail (HP:0001805) | 5.29648984 |
9 | Abnormality of nail color (HP:0100643) | 5.17790841 |
10 | Abnormality of the corticospinal tract (HP:0002492) | 4.81115995 |
11 | Atrophic scars (HP:0001075) | 4.79308544 |
12 | Myokymia (HP:0002411) | 4.79110857 |
13 | Alopecia of scalp (HP:0002293) | 4.65746718 |
14 | Cerebral inclusion bodies (HP:0100314) | 4.51095124 |
15 | Palmoplantar hyperkeratosis (HP:0000972) | 4.42288443 |
16 | Nail dystrophy (HP:0008404) | 4.34672525 |
17 | Right ventricular cardiomyopathy (HP:0011663) | 4.18310915 |
18 | Palmar hyperkeratosis (HP:0010765) | 4.14589477 |
19 | Termporal pattern (HP:0011008) | 4.03875684 |
20 | Insidious onset (HP:0003587) | 4.03875684 |
21 | Ridged nail (HP:0001807) | 3.85563287 |
22 | Onion bulb formation (HP:0003383) | 3.81177859 |
23 | Abnormal blistering of the skin (HP:0008066) | 3.81162289 |
24 | Parakeratosis (HP:0001036) | 3.66548430 |
25 | Ankle clonus (HP:0011448) | 3.64678016 |
26 | Intention tremor (HP:0002080) | 3.57464615 |
27 | Peripheral hypomyelination (HP:0007182) | 3.56781191 |
28 | Supranuclear gaze palsy (HP:0000605) | 3.55143059 |
29 | Spastic gait (HP:0002064) | 3.51720353 |
30 | Scanning speech (HP:0002168) | 3.31013302 |
31 | Ankyloglossia (HP:0010296) | 3.29281005 |
32 | Hypoplasia of dental enamel (HP:0006297) | 3.25438371 |
33 | Pterygium (HP:0001059) | 3.21246405 |
34 | Dysmetria (HP:0001310) | 3.16762222 |
35 | Pili torti (HP:0003777) | 3.12689041 |
36 | Action tremor (HP:0002345) | 3.06383963 |
37 | Focal motor seizures (HP:0011153) | 3.03206952 |
38 | Axonal loss (HP:0003447) | 2.94335291 |
39 | Abnormality of oral frenula (HP:0000190) | 2.88278264 |
40 | Sensory axonal neuropathy (HP:0003390) | 2.77927535 |
41 | Intrahepatic cholestasis (HP:0001406) | 2.76294395 |
42 | Urinary urgency (HP:0000012) | 2.74780366 |
43 | Sparse eyelashes (HP:0000653) | 2.74551148 |
44 | Abnormal hair laboratory examination (HP:0003328) | 2.72545342 |
45 | Retinal dysplasia (HP:0007973) | 2.69459443 |
46 | Abnormal auditory evoked potentials (HP:0006958) | 2.67739534 |
47 | Selective tooth agenesis (HP:0001592) | 2.67698466 |
48 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.67047725 |
49 | Aplasia of the phalanges of the hand (HP:0009802) | 2.67047725 |
50 | Aplasia involving bones of the extremities (HP:0009825) | 2.67047725 |
51 | Abnormality of placental membranes (HP:0011409) | 2.65076719 |
52 | Amniotic constriction ring (HP:0009775) | 2.65076719 |
53 | Interstitial pulmonary disease (HP:0006530) | 2.64491400 |
54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.60571890 |
55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.60571890 |
56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.60571890 |
57 | Fragile skin (HP:0001030) | 2.59343245 |
58 | Torticollis (HP:0000473) | 2.56016814 |
59 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.55568086 |
60 | Oral leukoplakia (HP:0002745) | 2.54656454 |
61 | Subacute progressive viral hepatitis (HP:0006572) | 2.53113432 |
62 | Xerostomia (HP:0000217) | 2.51003770 |
63 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.49550416 |
64 | Flat acetabular roof (HP:0003180) | 2.47949971 |
65 | Hypotrichosis (HP:0001006) | 2.47852083 |
66 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.46980629 |
67 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.44084004 |
68 | Osteolytic defects of the hand bones (HP:0009699) | 2.44084004 |
69 | Slow saccadic eye movements (HP:0000514) | 2.43364772 |
70 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.43354409 |
71 | Lower limb muscle weakness (HP:0007340) | 2.41954996 |
72 | Megalencephaly (HP:0001355) | 2.40873867 |
73 | Clumsiness (HP:0002312) | 2.39865231 |
74 | Vascular calcification (HP:0004934) | 2.38638761 |
75 | Short nail (HP:0001799) | 2.37570608 |
76 | Focal seizures (HP:0007359) | 2.37027125 |
77 | Alacrima (HP:0000522) | 2.36839631 |
78 | Clonus (HP:0002169) | 2.36650270 |
79 | Pustule (HP:0200039) | 2.36505098 |
80 | Erythema (HP:0010783) | 2.35032435 |
81 | Coronal craniosynostosis (HP:0004440) | 2.33887463 |
82 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.32863767 |
83 | Cheilitis (HP:0100825) | 2.32457943 |
84 | Hammertoe (HP:0001765) | 2.30749991 |
85 | Natal tooth (HP:0000695) | 2.29528741 |
86 | Spastic tetraparesis (HP:0001285) | 2.26182408 |
87 | Popliteal pterygium (HP:0009756) | 2.25774303 |
88 | Abnormality of the salivary glands (HP:0010286) | 2.24337199 |
89 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.22940368 |
90 | Lip pit (HP:0100267) | 2.22110261 |
91 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.21835366 |
92 | Dysdiadochokinesis (HP:0002075) | 2.21064341 |
93 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.20615495 |
94 | Periodontitis (HP:0000704) | 2.20261198 |
95 | Cerebral hemorrhage (HP:0001342) | 2.19193255 |
96 | Arterial tortuosity (HP:0005116) | 2.17833854 |
97 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.17063721 |
98 | Craniofacial dystonia (HP:0012179) | 2.16863000 |
99 | Hypophosphatemic rickets (HP:0004912) | 2.16288030 |
100 | Bowel incontinence (HP:0002607) | 2.14893241 |
101 | Oligodontia (HP:0000677) | 2.11928616 |
102 | Split foot (HP:0001839) | 2.11205048 |
103 | Thickened helices (HP:0000391) | 2.10798660 |
104 | Increased circulating renin level (HP:0000848) | 2.09987466 |
105 | Focal dystonia (HP:0004373) | 2.09800860 |
106 | Aplasia cutis congenita (HP:0001057) | 2.07879787 |
107 | Premature loss of primary teeth (HP:0006323) | 2.07461930 |
108 | Trismus (HP:0000211) | 2.06778687 |
109 | Nuclear cataract (HP:0100018) | 2.05515146 |
110 | Cerebral hypomyelination (HP:0006808) | 2.05513908 |
111 | Amyloidosis (HP:0011034) | 2.05419211 |
112 | Neuronal loss in central nervous system (HP:0002529) | 2.05259565 |
113 | Postural instability (HP:0002172) | 2.03589458 |
114 | Distal sensory impairment (HP:0002936) | 2.01277050 |
115 | Micronodular cirrhosis (HP:0001413) | 2.01096356 |
116 | Hyperlipoproteinemia (HP:0010980) | 2.00645285 |
117 | Vertebral compression fractures (HP:0002953) | 2.00393791 |
118 | Peripheral demyelination (HP:0011096) | 1.99910390 |
119 | Cardiovascular calcification (HP:0011915) | 1.99369055 |
120 | Corneal erosion (HP:0200020) | 1.98940011 |
121 | Anxiety (HP:0000739) | 1.98916774 |
122 | Deep venous thrombosis (HP:0002625) | 1.98463605 |
123 | Malnutrition (HP:0004395) | 1.97972818 |
124 | Urinary incontinence (HP:0000020) | 1.97960110 |
125 | Abnormal large intestine physiology (HP:0012700) | 1.97471800 |
126 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.96940782 |
127 | Distal lower limb muscle weakness (HP:0009053) | 1.96538130 |
128 | Pheochromocytoma (HP:0002666) | 1.96137858 |
129 | Glucose intolerance (HP:0000833) | 1.95840920 |
130 | Broad face (HP:0000283) | 1.94812888 |
131 | Xanthomatosis (HP:0000991) | 1.94218449 |
132 | Decreased motor nerve conduction velocity (HP:0003431) | 1.92500554 |
133 | Foot dorsiflexor weakness (HP:0009027) | 1.92396100 |
134 | Metabolic alkalosis (HP:0200114) | 1.90693701 |
135 | Absent eyelashes (HP:0000561) | 1.89249625 |
136 | Leukodystrophy (HP:0002415) | 1.88537498 |
137 | Focal segmental glomerulosclerosis (HP:0000097) | 1.87738122 |
138 | Autoamputation (HP:0001218) | 1.86608888 |
139 | Advanced eruption of teeth (HP:0006288) | 1.85984844 |
140 | Polygenic inheritance (HP:0010982) | 1.84335804 |
141 | Palmoplantar keratoderma (HP:0000982) | 1.84244282 |
142 | Choroideremia (HP:0001139) | 1.83994395 |
143 | Type II lissencephaly (HP:0007260) | 1.83759154 |
144 | Epileptic encephalopathy (HP:0200134) | 1.83437606 |
145 | Mutism (HP:0002300) | 1.82990764 |
146 | Decreased lacrimation (HP:0000633) | 1.82362846 |
147 | Anteriorly placed anus (HP:0001545) | 1.80711368 |
148 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.80129349 |
149 | Ectropion (HP:0000656) | 1.79678768 |
150 | Abnormality of macrophages (HP:0004311) | 1.78684539 |
151 | Abnormality of the gastric mucosa (HP:0004295) | 1.78375159 |
152 | Hyperhidrosis (HP:0000975) | 1.77832628 |
153 | Tetraparesis (HP:0002273) | 1.77676434 |
154 | Carious teeth (HP:0000670) | 1.77269647 |
155 | Loss of speech (HP:0002371) | 1.76838265 |
156 | Hemiparesis (HP:0001269) | 1.76420097 |
157 | Turricephaly (HP:0000262) | 1.75694714 |
158 | Multifactorial inheritance (HP:0001426) | 1.75586195 |
159 | Skin ulcer (HP:0200042) | 1.74851048 |
160 | Glomerulosclerosis (HP:0000096) | 1.74558414 |
161 | Synostosis involving the elbow (HP:0003938) | 1.74398831 |
162 | Humeroradial synostosis (HP:0003041) | 1.74398831 |
163 | Abnormality of saccadic eye movements (HP:0000570) | 1.74108569 |
164 | Stridor (HP:0010307) | 1.73640403 |
165 | Woolly hair (HP:0002224) | 1.72694117 |
166 | Hypoplastic pelvis (HP:0008839) | 1.72090930 |
167 | Hypokalemic alkalosis (HP:0001949) | 1.71422484 |
168 | Abnormality of the foot musculature (HP:0001436) | 1.71328156 |
169 | Sparse scalp hair (HP:0002209) | 1.70816985 |
170 | Dehydration (HP:0001944) | 1.70815119 |
171 | Polar cataract (HP:0010696) | 1.70512443 |
172 | Hoarse voice (HP:0001609) | 1.69835274 |
173 | Recurrent bacterial skin infections (HP:0005406) | 1.69562915 |
174 | Spastic paraparesis (HP:0002313) | 1.69074413 |
175 | Hypodontia (HP:0000668) | 1.68618574 |
176 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.68076792 |
177 | Broad-based gait (HP:0002136) | 1.67371219 |
178 | Distal upper limb amyotrophy (HP:0007149) | 1.67315981 |
179 | Upper limb amyotrophy (HP:0009129) | 1.67315981 |
180 | Confusion (HP:0001289) | 1.66478934 |
181 | Spastic paraplegia (HP:0001258) | 1.66339011 |
182 | Bone pain (HP:0002653) | 1.65860411 |
183 | Poikiloderma (HP:0001029) | 1.65718691 |
184 | Esophageal atresia (HP:0002032) | 1.65659241 |
185 | Hypoplasia of the uterus (HP:0000013) | 1.65371653 |
186 | Akinesia (HP:0002304) | 1.65362714 |
187 | Depression (HP:0000716) | 1.64548794 |
188 | Hyperventilation (HP:0002883) | 1.63893915 |
189 | Vascular tortuosity (HP:0004948) | 1.62766730 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST1R | 6.66938827 |
2 | EPHA2 | 6.01893808 |
3 | STK39 | 4.84678897 |
4 | EPHA4 | 3.92508467 |
5 | EPHB1 | 3.31802003 |
6 | OXSR1 | 3.30536331 |
7 | MAPKAPK5 | 2.81295660 |
8 | IRAK3 | 2.76777765 |
9 | LMTK2 | 2.41743248 |
10 | PAK4 | 2.35037566 |
11 | MAP3K12 | 2.32714260 |
12 | PKN1 | 2.16314916 |
13 | NTRK1 | 2.15245266 |
14 | WNK4 | 2.02589995 |
15 | SIK3 | 2.01790424 |
16 | ERN1 | 1.98165209 |
17 | MAP3K3 | 1.96177089 |
18 | FGFR2 | 1.95746776 |
19 | BCR | 1.94977163 |
20 | RIPK1 | 1.88134045 |
21 | NTRK3 | 1.78156107 |
22 | LATS2 | 1.76842686 |
23 | TYRO3 | 1.73666016 |
24 | MET | 1.69474220 |
25 | KSR2 | 1.68045352 |
26 | MAP3K9 | 1.67912260 |
27 | MOS | 1.65032420 |
28 | UHMK1 | 1.63112824 |
29 | SGK494 | 1.62132321 |
30 | SGK223 | 1.62132321 |
31 | NME2 | 1.61979406 |
32 | TNIK | 1.60600203 |
33 | MARK1 | 1.58597645 |
34 | STK24 | 1.55128210 |
35 | MAP3K2 | 1.54923538 |
36 | EPHB2 | 1.54714449 |
37 | CAMK2B | 1.50184823 |
38 | PBK | 1.49334157 |
39 | SIK1 | 1.49052044 |
40 | WNK1 | 1.48791966 |
41 | CASK | 1.40280878 |
42 | STK10 | 1.33379553 |
43 | PAK6 | 1.33303065 |
44 | CDK19 | 1.32971577 |
45 | PIM2 | 1.29644664 |
46 | CDK5 | 1.24543769 |
47 | PRKD3 | 1.23274479 |
48 | PNCK | 1.19610764 |
49 | TGFBR2 | 1.18596356 |
50 | PDGFRA | 1.18272545 |
51 | CSNK1A1L | 1.17960136 |
52 | FGR | 1.17431450 |
53 | LIMK1 | 1.15879236 |
54 | CSNK1G2 | 1.15733329 |
55 | NEK6 | 1.15472559 |
56 | MAPK15 | 1.14798498 |
57 | CSNK1G3 | 1.14514142 |
58 | DAPK2 | 1.14474721 |
59 | NTRK2 | 1.11347758 |
60 | LATS1 | 1.10705599 |
61 | KSR1 | 1.10038736 |
62 | MAP3K13 | 1.05633798 |
63 | MARK2 | 1.05197599 |
64 | ROCK2 | 1.03551849 |
65 | CAMK2D | 1.02662743 |
66 | FES | 1.01151957 |
67 | ERBB4 | 1.01110868 |
68 | TESK1 | 1.00843529 |
69 | CAMK2A | 0.98332568 |
70 | MAP3K14 | 0.96582537 |
71 | PAK3 | 0.94912829 |
72 | CAMK2G | 0.94623564 |
73 | IRAK4 | 0.94600877 |
74 | CSNK1G1 | 0.94215449 |
75 | TRPM7 | 0.91392655 |
76 | TESK2 | 0.89346733 |
77 | PTK6 | 0.85622912 |
78 | MST4 | 0.84988808 |
79 | PDPK1 | 0.83124827 |
80 | PHKG2 | 0.83014885 |
81 | PHKG1 | 0.83014885 |
82 | PRKD1 | 0.81774516 |
83 | STK38 | 0.81022794 |
84 | MINK1 | 0.79897027 |
85 | TAOK1 | 0.77896874 |
86 | TAOK2 | 0.77638208 |
87 | CDK14 | 0.76498374 |
88 | TTN | 0.74592020 |
89 | TBK1 | 0.74395505 |
90 | PRKCE | 0.74344957 |
91 | PRPF4B | 0.71525232 |
92 | MAP3K6 | 0.71343202 |
93 | SMG1 | 0.71104806 |
94 | ICK | 0.70225433 |
95 | PRKCH | 0.70008483 |
96 | CLK1 | 0.69875777 |
97 | MAP3K4 | 0.69780995 |
98 | PRKCQ | 0.69624245 |
99 | CDK15 | 0.69428731 |
100 | CAMK1G | 0.69184692 |
101 | CSK | 0.66397005 |
102 | CAMKK1 | 0.65240967 |
103 | CDK18 | 0.64568605 |
104 | STK11 | 0.64219793 |
105 | DDR2 | 0.63604350 |
106 | FYN | 0.63134537 |
107 | MAP2K3 | 0.62919596 |
108 | TRIM28 | 0.61414289 |
109 | MAP2K2 | 0.61120621 |
110 | MAPK13 | 0.60962086 |
111 | RAF1 | 0.59473651 |
112 | CDK11A | 0.59096030 |
113 | FLT3 | 0.58449516 |
114 | MAP3K1 | 0.57146029 |
115 | TRIB3 | 0.57014598 |
116 | BMPR2 | 0.55679749 |
117 | MAP3K8 | 0.54864507 |
118 | MUSK | 0.54622350 |
119 | SGK1 | 0.53979593 |
120 | MAP2K4 | 0.53842389 |
121 | DMPK | 0.53491272 |
122 | BRAF | 0.52769160 |
123 | DYRK2 | 0.52739038 |
124 | LRRK2 | 0.52608407 |
125 | ZAP70 | 0.52292493 |
126 | CDK12 | 0.52082829 |
127 | RET | 0.51788405 |
128 | CSF1R | 0.51741402 |
129 | FER | 0.51242454 |
130 | GSK3A | 0.51130650 |
131 | PDK1 | 0.50206716 |
132 | ERBB3 | 0.49982552 |
133 | RIPK4 | 0.49406884 |
134 | ABL2 | 0.49039131 |
135 | ARAF | 0.48792216 |
136 | SCYL2 | 0.48732312 |
137 | MAPKAPK2 | 0.48407725 |
138 | CSNK1A1 | 0.45985075 |
139 | GRK5 | 0.45705131 |
140 | PTK2B | 0.45689691 |
141 | PINK1 | 0.45050167 |
142 | CAMKK2 | 0.44392786 |
143 | YES1 | 0.44047748 |
144 | PDGFRB | 0.43279155 |
145 | CAMK1 | 0.42708738 |
146 | CSNK1D | 0.42567006 |
147 | NEK1 | 0.41686929 |
148 | PRKG2 | 0.41331624 |
149 | PRKCZ | 0.40807253 |
150 | STK38L | 0.40419445 |
151 | PTK2 | 0.40020652 |
152 | PRKG1 | 0.39907795 |
153 | BMX | 0.39774284 |
154 | MYLK | 0.38032706 |
155 | IRAK2 | 0.37935960 |
156 | PRKCI | 0.36258269 |
157 | PRKD2 | 0.35020070 |
158 | EIF2AK1 | 0.30825757 |
159 | CDK6 | 0.30553030 |
160 | SGK3 | 0.29687049 |
161 | JAK3 | 0.27886127 |
162 | CDK8 | 0.27077036 |
163 | IKBKB | 0.25630765 |
164 | MAP3K5 | 0.25296806 |
165 | MTOR | 0.24772118 |
166 | JAK1 | 0.24647982 |
167 | EIF2AK3 | 0.24476567 |
168 | MAP2K6 | 0.23976759 |
169 | IRAK1 | 0.23640437 |
170 | STK3 | 0.23497834 |
171 | FGFR1 | 0.22073904 |
172 | MELK | 0.21259788 |
173 | ILK | 0.20750389 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.61070163 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48206950 |
3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.30269222 |
4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.29194038 |
5 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.02853916 |
6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.61745220 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58338232 |
8 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.11330555 |
9 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.04619644 |
10 | Galactose metabolism_Homo sapiens_hsa00052 | 2.02139875 |
11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.97568993 |
12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.95166796 |
13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84063003 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78129274 |
15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73152677 |
16 | Adherens junction_Homo sapiens_hsa04520 | 1.71932657 |
17 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.70978073 |
18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.69717967 |
19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.65823251 |
20 | Legionellosis_Homo sapiens_hsa05134 | 1.65413920 |
21 | Bladder cancer_Homo sapiens_hsa05219 | 1.62610949 |
22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.59897268 |
23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59800063 |
24 | Salmonella infection_Homo sapiens_hsa05132 | 1.59156940 |
25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58162789 |
26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.58014357 |
27 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.57982797 |
28 | Thyroid cancer_Homo sapiens_hsa05216 | 1.57946272 |
29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.56428741 |
30 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.56382653 |
31 | Focal adhesion_Homo sapiens_hsa04510 | 1.52577872 |
32 | Amoebiasis_Homo sapiens_hsa05146 | 1.52016618 |
33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.47621720 |
34 | Shigellosis_Homo sapiens_hsa05131 | 1.46697678 |
35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43688156 |
36 | Morphine addiction_Homo sapiens_hsa05032 | 1.43140233 |
37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41925178 |
38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.38901279 |
39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.37372517 |
40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.37222580 |
41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.36904150 |
42 | Malaria_Homo sapiens_hsa05144 | 1.34272704 |
43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33653369 |
44 | Axon guidance_Homo sapiens_hsa04360 | 1.33076870 |
45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29290606 |
46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.27999045 |
47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25144734 |
48 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.24131421 |
49 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.20850486 |
50 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.19650295 |
51 | Lysosome_Homo sapiens_hsa04142 | 1.19550476 |
52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19249311 |
53 | Olfactory transduction_Homo sapiens_hsa04740 | 1.19029061 |
54 | Salivary secretion_Homo sapiens_hsa04970 | 1.18401987 |
55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.18175300 |
56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.17790263 |
57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17732630 |
58 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.17722516 |
59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.17074738 |
60 | Nicotine addiction_Homo sapiens_hsa05033 | 1.16352857 |
61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.15960439 |
62 | Hepatitis C_Homo sapiens_hsa05160 | 1.15755783 |
63 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.15730138 |
64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14519787 |
65 | Long-term depression_Homo sapiens_hsa04730 | 1.14382545 |
66 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.12466813 |
67 | Apoptosis_Homo sapiens_hsa04210 | 1.11117783 |
68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10771911 |
69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10690332 |
70 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.08514012 |
71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08082788 |
72 | Renin secretion_Homo sapiens_hsa04924 | 1.05075443 |
73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04715203 |
74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.04702766 |
75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.04398027 |
76 | Influenza A_Homo sapiens_hsa05164 | 1.03204363 |
77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02788280 |
78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02185149 |
79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00953565 |
80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00857846 |
81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00341561 |
82 | Bile secretion_Homo sapiens_hsa04976 | 0.98868964 |
83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.98679109 |
84 | Pertussis_Homo sapiens_hsa05133 | 0.98561364 |
85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.98102133 |
86 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.97895010 |
87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.97269735 |
88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96957050 |
89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96836955 |
90 | Tuberculosis_Homo sapiens_hsa05152 | 0.94570383 |
91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94540146 |
92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92603792 |
93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91876349 |
94 | Gap junction_Homo sapiens_hsa04540 | 0.87209565 |
95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87118065 |
96 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83637588 |
97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82155732 |
98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82152078 |
99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81558533 |
100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81531751 |
101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81032975 |
102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80849384 |
103 | Prion diseases_Homo sapiens_hsa05020 | 0.79689449 |
104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77380638 |
105 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77116382 |
106 | Measles_Homo sapiens_hsa05162 | 0.76180301 |
107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76049507 |
108 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.75088612 |
109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74405521 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73587267 |
111 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72942154 |
112 | Insulin secretion_Homo sapiens_hsa04911 | 0.72372086 |
113 | Tight junction_Homo sapiens_hsa04530 | 0.72335793 |
114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.71374509 |
115 | Hepatitis B_Homo sapiens_hsa05161 | 0.71188308 |
116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70984396 |
117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70600286 |
118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70557068 |
119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69938379 |
120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69583402 |
121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68595294 |
122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68436201 |
123 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.68364326 |
124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66139538 |
125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65984438 |
126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65305654 |
127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64576359 |
128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64471357 |
129 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63278099 |
130 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62064211 |
131 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61656957 |
132 | Phagosome_Homo sapiens_hsa04145 | 0.61608992 |
133 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61278168 |
134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61021076 |
135 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60859964 |
136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60777221 |
137 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59897223 |
138 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59717323 |
139 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59617611 |
140 | Mineral absorption_Homo sapiens_hsa04978 | 0.58686754 |
141 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57567222 |
142 | Peroxisome_Homo sapiens_hsa04146 | 0.57374290 |
143 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56571477 |
144 | ABC transporters_Homo sapiens_hsa02010 | 0.56531643 |
145 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56392656 |
146 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56093660 |
147 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55921016 |
148 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55801600 |
149 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55474090 |
150 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55105801 |
151 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54345215 |
152 | Insulin resistance_Homo sapiens_hsa04931 | 0.53927332 |
153 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53276065 |
154 | Endocytosis_Homo sapiens_hsa04144 | 0.52865855 |
155 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52625112 |
156 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.51810933 |
157 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50580063 |
158 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50546755 |
159 | Taste transduction_Homo sapiens_hsa04742 | 0.50296267 |
160 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50249457 |
161 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50183472 |
162 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49346738 |
163 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49198688 |
164 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47872315 |
165 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47528349 |
166 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46895613 |
167 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46748296 |
168 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46351385 |
169 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46220341 |
170 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45933458 |
171 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44560694 |
172 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44327284 |
173 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44000437 |
174 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43845485 |
175 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43562804 |
176 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43488153 |
177 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43190158 |
178 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42804684 |
179 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41863708 |
180 | Melanogenesis_Homo sapiens_hsa04916 | 0.41801629 |
181 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40586733 |
182 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40129637 |